Results 51 to 60 of about 787 (175)
Dupilumab in Paediatric Netherton Syndrome: Two Case Reports and a Review of the Literature
ABSTRACT Netherton Syndrome (NS) is a rare genodermatosis characterised by a triad of ichthyosiform erythroderma, an atopic diathesis, and trichorrhexis invaginata, for which no effective management is currently approved in Australia. Dupilumab has demonstrated considerable effectiveness in the treatment of atopic conditions in the paediatric ...
Jacqueline Tu +5 more
wiley +1 more source
S1 Guideline: Therapy of generalized pustular psoriasis
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner +17 more
wiley +1 more source
Efficacy and safety of spesolimab in the treatment of Generalized Pustular Psoriasis: a systematic review. [PDF]
A psoríase pustulosa generalizada (PPG) é uma doença rara e potencialmente fatal, caracterizada por uma erupção generalizada de pústulas estéreis. O spesolimab é um novo anticorpo monoclonal que tem como alvo o recetor IL36RN, sendo dirigido para o ...
Cristiana Maria Louzada de Almeida
core +1 more source
Introduction: Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening form of psoriasis, characterized by widespread sterile pustules and systemic symptoms.
Anne Hald Rittig +3 more
doaj +1 more source
This case series review examines the efficacy of spesolimab in managing generalized pustular psoriasis (GPP) flares, including those exacerbated by coronavirus disease 2019 (COVID-19) vaccination.
Chun-Bing Chen +3 more
doaj +1 more source
Management of Refractory and Difficult‐To‐Treat Inflammatory Bowel Disease: An Expert Opinion Review
This expert opinion offers a practical framework for refractory and difficult‐to‐treat IBD: confirm inflammation objectively, distinguish pharmacologic from structural and functional disease, and then escalate. Across ten clinical questions, the evidence is often limited to case series, and the resulting statements are identified as expert opinion ...
Filiz Akyuz +10 more
wiley +1 more source
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease [PDF]
Unmet needs in the treatment of psoriasis call for novel therapeutic strategies. Pustular psoriasis and psoriatic arthritis often represent a therapeutic challenge.
Puig Sanz, Lluís +3 more
core +1 more source
Eingun James Song,1,* Clive Liu2,* 1Frontier Dermatology, Mill Creek, Washington, USA; 2Bellevue Dermatology Clinic, Bellevue, Washington, USA*These authors contributed equally to this workCorrespondence: Dr Eingun James Song, Email Eingun.Song ...
Song EJ, Liu C
doaj
Abstract Evaluation of the pharmacokinetics (PK) of new drugs in Japanese individuals is regularly requested by the Japanese regulatory agency prior to participation in global clinical trials or for bridging approaches for regulatory approval. However, the need for PK assessments in the Japanese population may be less compelling for monoclonal ...
Paridhi Gupta +2 more
wiley +1 more source
Analysis of the German compassionate use program on spesolimab in patients with generalized pustular psoriasis: evidence outside of clinical trials [PDF]
Background Generalized pustular psoriasis (GPP) is a potentially life-threatening orphan disease. Interleukin (IL)-36 is a known pathogenetic key driver of GPP.
Thölken, Karisa +11 more
core +1 more source

